These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1727860)

  • 21. Surfactant protein A regulates complement activation.
    Watford WT; Wright JR; Hester CG; Jiang H; Frank MM
    J Immunol; 2001 Dec; 167(11):6593-600. PubMed ID: 11714829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T and B cell epitope mapping of Taenia solium paramyosin.
    Vázquez-Talavera J; Solís CF; Medina-Escutia E; López ZM; Proaño J; Correa D; Laclette JP
    Parasite Immunol; 2001 Nov; 23(11):575-9. PubMed ID: 11703808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence and preliminary characterisation of a Taenia saginata oncosphere gene homologue of the small heat-shock protein family.
    Benitez L; Harrison LJ; Parkhouse RM; Garate T
    Parasitol Res; 1998 May; 84(5):423-5. PubMed ID: 9610643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paramyosin-enhanced clearance of Brugia malayi microfilaremia in mice.
    Nanduri J; Kazura JW
    J Immunol; 1989 Nov; 143(10):3359-63. PubMed ID: 2809205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and properties of human C1 inhibitor.
    Sim RB; Reboul A
    Methods Enzymol; 1981; 80 Pt C():43-54. PubMed ID: 6281621
    [No Abstract]   [Full Text] [Related]  

  • 29. The B cell epitope of paramyosin recognized by a protective monoclonal IgE antibody to Schistosoma japonicum.
    Nara T; Tanabe K; Mahakunkijcharoen Y; Osada Y; Matsumoto N; Kita K; Kojima S
    Vaccine; 1997 Jan; 15(1):79-84. PubMed ID: 9041670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A newly discovered function for C1 inhibitor, removal of the entire C1qr2s2 complex from immobilized human IgG subclasses.
    Chen CH; Boackle RJ
    Clin Immunol Immunopathol; 1998 Apr; 87(1):68-74. PubMed ID: 9576012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
    van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
    J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene structure of Taenia solium paramyosin.
    Vargas-Parada L; Laclette JP
    Parasitol Res; 2003 Mar; 89(5):375-8. PubMed ID: 12632150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of fucoidan with the proteins of the complement classical pathway.
    Tissot B; Montdargent B; Chevolot L; Varenne A; Descroix S; Gareil P; Daniel R
    Biochim Biophys Acta; 2003 Sep; 1651(1-2):5-16. PubMed ID: 14499584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells.
    Fonseca CT; Cunha-Neto E; Kalil J; Jesus AR; Correa-Oliveira R; Carvalho EM; Oliveira SC
    Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):63-6. PubMed ID: 15486637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of an immunodiagnostic Taenia solium coproantigen.
    Maass M; Delgado E; Knobloch J
    Trop Med Parasitol; 1992 Sep; 43(3):201-2. PubMed ID: 1470844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host-parasite interactions in Taenia solium cysticercosis.
    White AC; Tato P; Molinari JL
    Infect Agents Dis; 1992 Aug; 1(4):185-93. PubMed ID: 1365544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paramyosin isoforms of Schistosoma mansoni are phosphorylated and localized in a large variety of muscle types.
    Schmidt J; Bodor O; Gohr L; Kunz W
    Parasitology; 1996 May; 112 ( Pt 5)():459-67. PubMed ID: 8677135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.